Filer Snapshot

DA32 Life Science Tech Acquisition Corp. SEC EDGAR Filings

SEC filings, ownership reports, and insider transactions for CIK 0001863294.

Entity Type

Company

Total Filings

77

Latest Filing

07 Feb 2024

Industry

Blank Checks

Save this filer page for the next filing cycle

Keep this page in your research queue, then return to compare new filings with prior context.

Save and revisit

Save this filer page

Create a free account to keep this page in your watchlists and return after a new SEC filing changes the record here.

Best next steps

Start with the latest filings table, then open the strongest context page for this filer.

  • Use the filings table to verify the newest submission, form type, and report period.
  • Open the deeper context page only when this filer actually has insider or ownership signal.
Source: SEC Schedule 13D/G

SC 13G/A filed on 07 Feb 2024 for CIK 0001863294.

View Source Filing
Business address
345 Park Avenue South, 12 Th Floor, New York, NY, 10010
State of incorporation
DE
Fiscal year end
31 December

Quick Takeaways

  • DA32 Life Science Tech Acquisition Corp. is an SEC filer tracked under CIK 0001863294.
  • 77 filings are listed on this profile.
  • Common form coverage includes SC 13G/A, 4, 15-12G and more.

What Changed

  • Latest filing: SC 13G/A filed on 07 Feb 2024.
  • Report period: not specified in filing header.

Why This Matters

  • You can quote filing dates and form types directly from the SEC record on this page.
  • Use this profile before deeper ownership or insider analysis to confirm filing history context.

Source Evidence

Source: SEC Schedule 13D/G

SC 13G/A filed on 07 Feb 2024 for CIK 0001863294.

View Source Filing

Return Loop

Why revisit this filer page

A newly filed SC 13G/A can change the filing history, ownership context, or next research path for DA32 Life Science Tech Acquisition Corp..

Latest source-backed update
SC 13G/A filed 07 Feb 2024
Why come back
Revisit after a new SEC filing appears to compare the updated record with prior filings.
  • Latest filing on record: SC 13G/A filed 07 Feb 2024.
  • Save this filer if you want a stable place to return after the next filing cycle.
  • Open the latest filing table or ownership context to verify what changed.

Filer freshness comes from SEC EDGAR submission history and related source-backed ownership or portfolio filings when available.

Filer Overview

DA32 Life Science Tech Acquisition Corp. has filed 77 SEC EDGAR filings since 28 May 2021. Common forms include SC 13G/A, 4, 15-12G, SC 13D/A and more.

Latest Filings

Recent SEC filings for DA32 Life Science Tech Acquisition Corp. with direct links to document and filing folders.

Form type Document Filing Description Filing date Reporting date File number(s)
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A FORM SC 13G/A 07 Feb 2024 005-92756
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A 13G/A DALS 11 Sep 2023 005-92756
4 Open 4 document View SEC filing for 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 10 Aug 2023 28 Jul 2023
4 Open 4 document View SEC filing for 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 10 Aug 2023 28 Jul 2023
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A 08 Aug 2023 005-92756
15-12G Open 15-12G document View SEC filing for 15-12G 15-12G 08 Aug 2023 001-40676
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A ARCH VENTURE FUND XI, L.P. - DA32 LIFE SCIENCE -- SCH 13G/A(#1) 04 Aug 2023 005-92756
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A SC 13D/A 02 Aug 2023 005-92756
4 Open 4 document View SEC filing for 4 01 Aug 2023 28 Jul 2023
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A 01 Aug 2023 005-92756
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A SC 13D/A 01 Aug 2023 005-92756
25-NSE Open 25-NSE document View SEC filing for 25-NSE 28 Jul 2023 333-257679
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 21 Jul 2023 21 Jul 2023 001-40676
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A SC 13G/A 15 May 2023 005-92756
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q 10-Q 12 May 2023 31 Mar 2023 001-40676
SC 13G Open SC 13G document View SEC filing for SC 13G DALS 13G 10 Apr 2023 005-92756
10-K Open 10-K document | Open XBRL data View SEC filing for 10-K FORM 10-K 29 Mar 2023 31 Dec 2022 001-40676
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A FORM SC 13G/A 14 Feb 2023 005-92756
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A SEC SCHEDULE 13G 06 Feb 2023 005-92756
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A 06 Feb 2023 005-92756
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A 31 Jan 2023 005-92756
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q 10-Q 10 Nov 2022 30 Sep 2022 001-40676
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q FORM 10-Q 15 Aug 2022 30 Jun 2022 001-40676
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q FORM 10-Q 13 May 2022 31 Mar 2022 001-40676
10-K Open 10-K document | Open XBRL data View SEC filing for 10-K FORM 10-K 31 Mar 2022 31 Dec 2021 001-40676
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A SEC SCHEDULE 13G 10 Feb 2022 005-92756
SC 13G Open SC 13G document View SEC filing for SC 13G FORM SC 13G 07 Feb 2022 005-92756
SC 13G Open SC 13G document View SEC filing for SC 13G 04 Feb 2022 005-92756
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A SEC SCHEDULE 13G 04 Feb 2022 005-92756
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A SEC SCHEDULE 13G 04 Feb 2022 005-92756
SC 13G Open SC 13G document View SEC filing for SC 13G 02 Feb 2022 005-92756
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q FORM 10-Q 15 Nov 2021 30 Sep 2021 001-40676
SC 13G Open SC 13G document View SEC filing for SC 13G SEC SCHEDULE 13G 10 Aug 2021 005-92756
SC 13D Open SC 13D document View SEC filing for SC 13D SC 13D 10 Aug 2021 005-92756
SC 13D Open SC 13D document View SEC filing for SC 13D SC 13D 10 Aug 2021 005-92756
SC 13D Open SC 13D document View SEC filing for SC 13D SC 13D 10 Aug 2021 005-92756
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 09 Aug 2021 05 Aug 2021
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 09 Aug 2021 05 Aug 2021
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 09 Aug 2021 05 Aug 2021
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 09 Aug 2021 05 Aug 2021
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 09 Aug 2021 05 Aug 2021
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 09 Aug 2021 05 Aug 2021
SC 13G Open SC 13G document View SEC filing for SC 13G SC 13G 09 Aug 2021 005-92756
SC 13D Open SC 13D document View SEC filing for SC 13D SC 13D 09 Aug 2021 005-92756
SC 13G Open SC 13G document View SEC filing for SC 13G SEC SCHEDULE 13G 09 Aug 2021 005-92756
8-K Open 8-K document View SEC filing for 8-K FORM 8-K 05 Aug 2021 30 Jul 2021 001-40676
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 03 Aug 2021 30 Jul 2021
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 03 Aug 2021 30 Jul 2021
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 03 Aug 2021 30 Jul 2021
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 03 Aug 2021 30 Jul 2021
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 03 Aug 2021 30 Jul 2021
8-K Open 8-K document View SEC filing for 8-K FORM 8-K 30 Jul 2021 27 Jul 2021 001-40676
424B4 Open 424B4 document View SEC filing for 424B4 424B4 29 Jul 2021 333-257679
EFFECT Open EFFECT document View SEC filing for EFFECT 27 Jul 2021 333-257679
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 27 Jul 2021 27 Jul 2021
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 27 Jul 2021 27 Jul 2021
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 27 Jul 2021 27 Jul 2021
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 27 Jul 2021 27 Jul 2021
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 27 Jul 2021 27 Jul 2021
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 27 Jul 2021 27 Jul 2021
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 27 Jul 2021 27 Jul 2021
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 27 Jul 2021 27 Jul 2021
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 27 Jul 2021 27 Jul 2021
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 27 Jul 2021 27 Jul 2021
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 27 Jul 2021 27 Jul 2021
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 27 Jul 2021 27 Jul 2021
CERT Open CERT document View SEC filing for CERT 27 Jul 2021 001-40676
8-A12B Open 8-A12B document View SEC filing for 8-A12B 8-A12B 27 Jul 2021 001-40676
CORRESP Open CORRESP document View SEC filing for CORRESP 23 Jul 2021
CORRESP Open CORRESP document View SEC filing for CORRESP 23 Jul 2021
CORRESP Open CORRESP document View SEC filing for CORRESP 15 Jul 2021
S-1/A Open S-1/A document View SEC filing for S-1/A S-1/A 15 Jul 2021 333-257679
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 14 Jul 2021
S-1 Open S-1 document View SEC filing for S-1 S-1 02 Jul 2021 333-257679
CORRESP Open CORRESP document View SEC filing for CORRESP 02 Jul 2021
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 23 Jun 2021
DRS Open DRS document View SEC filing for DRS 28 May 2021 377-04948

About this filer

DA32 Life Science Tech Acquisition Corp. files with the SEC under CIK 0001863294. This page aggregates EDGAR filings and related ownership activity.

Industry: Blank Checks.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .